Premium
Pregabalin misuse: the next wave of prescription medication problems
Author(s) -
Murnion Bridin,
Conigrave Katherine M
Publication year - 2019
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/mja2.12056
Subject(s) - citation , medical prescription , medicine , pregabalin , library science , family medicine , psychiatry , computer science , nursing
Dispensing data indicate that pregabalin prescribing in Australia is rising rapidly, and the numbers of selfpoisonings and deaths are also increasing.1 This mirrors the European and North American experience of escalating misuse and harms.2,3 Although Australian guidelines recommend it only as second line treatment for neuropathic pain,4 pregabalin is now the seventh most expensive drug in terms of Pharmaceutical Benefits Scheme (PBS) expenditure.5